Beijing Biostar Pharmaceuticals (02563) Announces November 2025 Monthly Return on Securities Movements

Bulletin Express2025-12-03

Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Code: 02563) released its monthly return for the period ended 30 November 2025. The company’s total registered share capital remains RMB 364,588,000, comprising 216,720,857 H shares listed on the Hong Kong Stock Exchange and 147,867,143 unlisted shares, each with a par value of RMB 1.

The announcement indicates no changes to the issued share capital during the reporting month. Both categories of shares maintained the same balance as at the close of the preceding month. No share options, warrants, convertible securities, or other arrangements affected the company’s share capital within this period. The document was submitted on 03 December 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment